AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 SEP 6- (NewsRx Network) by N.R. Saltmarsh, staff medical writer - Hormone replacement therapy is associated with lower [HbA.sub.lc] levels in postmenopausal women, researchers at Kaiser Permanente have found.
"Little is known about how hormone replacement therapy (HRT) affects glucose metabolism in diabetes," noted A. Ferrara and colleagues working in the Northern California region, who proposed that glycemic control in women with diabetes may be further diminished by the hormonal changes of menopause.
Ferrara and associates recorded [HbA.sub.lc] and HRT status for 15,435 women with type 2 diabetes who were members of the Kaiser Permanente health maintenance organization, using records in the health plan's computerized laboratory and pharmacy systems. Subjects were surveyed for sociodemographic and clinical information.
Among the ethnically diverse group (55% non-Hispanic whites, 14% non-Hispanic blacks, 12% Hispanics, 11 % Asians, 4% "other" ethnic groups, and 4% with missing ethnicity data) the mean age was 64.7 years and 25% of the women were taking HRT, reported Ferrara and team. [HbA.sub.1c] levels were significantly lower in women currently using HRT than in women not using HRT (age-adjusted mean 7.9 [+ or -] 0.03 vs. 8.5 [+ or -] 0.02).
Even after accounting for age, ethnicity, education, obesity, hypoglycemic ...
Source: HighBeam Research, Hormone Replacement Therapy Improves Glycemic Control After...